EUVIMEDEUVIMED entdecken
MetaanalyseSystematische ÜbersichtOpen Access · CC BY 4.0

Agreement between self‐reported illicit drug use and biological samples: a systematic review and meta‐analysis

Chrianna Bharat iD, Paige Webb, Zachary Wilkinson, Rebecca McKetin iD, Jason Grebely iD, Michael Farrell iD, Adam Holland, Matthew Hickman iD, Lucy Thi Tran, Brodie Clark, Amy Peacock iD, Shane Darke iD und 2 weitere

Addiction · 2023-09 · 118 (9) · 1624-1648

DOI: 10.1111/add.16200 ↗

Kurz gefasst

Metaanalyse in der Zeitschrift Addiction, online erschienen am 04.05.2023. Verfasst von Chrianna Bharat und 13 weiteren Autor:innen. Beteiligte Einrichtung: National Drug and Alcohol Research Centre, UNSW Sydney, Randwick, NSW, Australia. Hauptthemen laut MEDLINE: Substance-Related Disorders, Illicit Drugs. Die Arbeit wurde bisher 136-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical Research Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Aims Studies often rely upon self‐report and biological testing methods for measuring illicit drug use, although evidence for their agreement is limited to specific populations and self‐report instruments. We aimed to examine comprehensively the evidence for agreement between self‐reported and biologically measured illicit drug use among all major illicit drug classes, biological indicators, populations and settings.

Methods

We systematically searched peer‐reviewed databases (Medline, Embase and PsycINFO) and grey literature. Included studies reported 2 × 2 table counts or agreement estimates comparing self‐reported and biologically measured use published up to March 2022. With biological results considered to be the reference standard and use of random‐effect regression models, we evaluated pooled estimates for overall agreement (primary outcome), sensitivity, specificity, false omission rates (proportion reporting no use that test positive) and false discovery rates (proportion reporting use that test negative) by drug class, potential consequences attached to self‐report (i.e. work, legal or treatment impacts) and time‐frame of use. Heterogeneity was assessed by inspecting forest plots.

Results

From 7924 studies, we extracted data from 207 eligible studies. Overall agreement ranged from good to excellent (> 0.79). False omission rates were generally low, while false discovery rates varied by setting. Specificity was generally high but sensitivity varied by drug, sample type and setting. Self‐report in clinical trials and situations of no consequences was generally reliable. For urine, recent (i.e. past 1–4 days) self‐report produced lower sensitivity and false discovery rates than past month. Agreement was higher in studies that informed participants biological testing would occur (diagnostic odds ratio = 2.91, 95% confidence interval = 1.25–6.78). The main source of bias was biological assessments (51% studies).

Conclusions

While there are limitations associated with self‐report and biological testing to measure illicit drug use, overall agreement between the two methods is high, suggesting both provide good measures of illicit drug use. Recommended methods of biological testing are more likely to provide reliable measures of recent use if there are problems with self‐disclosure.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Substance-Related DisordersIllicit DrugsHumansSelf ReportSensitivity and Specificity

Stichwörter der Autor:innen

Agreementbiomarkersconcordancedrug testingillicit drug useself-reportsensitivityspecificity

Substanzen

Illicit Drugs

Autor:innen und Institutionen

  • National Drug and Alcohol Research Centre, UNSW Sydney, Randwick, NSW, Australia.
  • The Kirby Institute, UNSW Sydney, Randwick, NSW, Australia.
  • Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK.
  • School of Psychology, University of Tasmania, Hobart, TAS, Australia.
  • Doctoral and Master Degree Program in Toxicology, College of Pharmacy, Kaohsiung Medical University, Kaohsiung, Taiwan.

ORCID-Profile: Chrianna Bharat, Rebecca McKetin, Jason Grebely, Michael Farrell, Matthew Hickman, Amy Peacock, Shane Darke, Louisa Degenhardt

Förderung

  • Medical Research Council

Zitieren

APA

Bharat, C., Webb, P., Wilkinson, Z., McKetin, R., Grebely, J., Farrell, M., Holland, A., Hickman, M., Tran, L. T., Clark, B., Peacock, A., Darke, S., Li, J. H., & Degenhardt, L. (2023). Agreement between self‐reported illicit drug use and biological samples: a systematic review and meta‐analysis. Addiction, 118(9), 1624-1648. https://doi.org/10.1111/add.16200

Vancouver

Bharat C, Webb P, Wilkinson Z, McKetin R, Grebely J, Farrell M, et al. Agreement between self‐reported illicit drug use and biological samples: a systematic review and meta‐analysis. Addiction. 2023;118(9):1624-1648. doi:10.1111/add.16200

BibTeX
@article{Bharat2023,
  author = {Bharat, Chrianna and Webb, Paige and Wilkinson, Zachary and McKetin, Rebecca and Grebely, Jason and Farrell, Michael and Holland, Adam and Hickman, Matthew and Tran, Lucy Thi and Clark, Brodie and Peacock, Amy and Darke, Shane and Li, Jih-Heng and Degenhardt, Louisa},
  title = {Agreement between self‐reported illicit drug use and biological samples: a systematic review and meta‐analysis},
  journal = {Addiction},
  year = {2023},
  volume = {118},
  number = {9},
  pages = {1624--1648},
  doi = {10.1111/add.16200}
}
Kostenlos starten →